Skip to main content
Latest news
Browse specialties
Breast cancer Genitourinary cancers Lung & thoracic cancers
In focus
Next-generation sequencing: Emerging biomarkers in thyroid and NSCLCs ctDNA and bladder cancer: Current understanding and beyond ROS1 fusion-positive NSCLC NSCLC driver mutations: Discussing the importance of RET, ALK and ROS1 alterations in NSCLC Early-stage NSCLC management: Surgery, targeted treatment and immunotherapy ALK fusion-positive NSCLC: International approaches to management RET fusion-positive NSCLC: Informing on the use of pralsetinib for patients with RET fusion-positive, advanced NSCLC COVID-19 & cancer
Conferences
SABCS 2022 ESMO 2022 2022 ASCO Annual Meeting
About us
Medicine Matters Oncology
EXTENDED SEARCH
Top

09-02-2017 | Neuroendocrine tumors | Article

Web-based information and support for patients with a newly diagnosed neuroendocrine tumor: a feasibility study

Journal: Supportive Care in Cancer

Authors: Grietje Bouma, Lotte D. de Hosson, Claudia E. van Woerkom, Hennie van Essen, Geertruida H. de Bock, Jolien M. Admiraal, Anna K. L. Reyners, Annemiek M. E. Walenkamp

Publisher: Springer Berlin Heidelberg

Login to get access

Abstract

Purpose

Patients with a neuroendocrine tumor (NET) frequently experience physical and psychosocial complaints. Novel strategies to provide information to optimize supportive care in these patients are of interest. The aim of this study was to examine whether the use of a web-based system consisting of self-screening of problems and care needs, patient education, and self-referral to professional health care is feasible in NET patients and to evaluate their opinion on this.

Methods

Newly diagnosed NET patients were randomized between standard care (n = 10) or intervention with additional access to the web-based system (n = 10) during 12 weeks. Patients completed questionnaires regarding received information, distress, quality of life (QoL), and empowerment. The intervention group completed a semi-structured interview to assess patients’ opinion on the web-based system.

Results

The participation rate was 77% (20/26 invited patients) with no dropouts. The use of the web-based system had a negative effect on patients’ perception and satisfaction of received information (range Cohen’s d −0.88 to 0.13). Positive effects were found for distress (Cohen’s d 0.75), global QoL (subscale European Organization for Research and Treatment of Cancer (EORTC) QLQ-C30, Cohen’s d 0.46), resolving problems with social functioning and finding information (subscales EORTC QLQ-GINET 21, Cohen’s d 0.69, respectively, 1.04), and feeling informed (subscale empowerment questionnaire, Cohen’s d 0.51). The interview indicated that the web-based system was of additional value to standard care.

Conclusions

Use of this web-based system is feasible. Contradictory effects on informing and supporting NET patients were found and should be subject of further research.

Trial registration

Literature
1.
Oberg KE (2012) The management of neuroendocrine tumours: current and future medical therapy options. Clin Oncol 24:282–293CrossRef
2.
Ramage JK, Ahmed A, Ardill J, Bax N, Breen DJ, Caplin ME et al (2012) Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs). Gut 61:6–32CrossRefPubMed
3.
Tuinman MA, Gazendam-Donofrio SM, Hoekstra-Weebers JE (2008) Screening and referral for psychosocial distress in oncologic practice: use of the Distress Thermometer. Cancer 113:870–878CrossRefPubMed
4.
Frojd C, Larsson G, Lampic C, von Essen L (2007) Health related quality of life and psychosocial function among patients with carcinoid tumours. a longitudinal, prospective, and comparative study. Health Qual Life Outcomes 5:18CrossRefPubMedPubMedCentral
5.
Haugland T, Vatn MH, Veenstra M, Wahl AK, Natvig GK (2009) Health related quality of life in patients with neuroendocrine tumors compared with the general Norwegian population. Qual Life Res 18:719–726CrossRefPubMed
6.
Husson O, Mols F, van de Poll-Franse LV (2011) The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: a systematic review. Ann Oncol 22:761–772CrossRefPubMed
7.
Davies NJ, Kinman G, Thomas RJ, Bailey T (2008) Information satisfaction in breast and prostate cancer patients: implications for quality of life. Psychooncology 17:1048–1052CrossRefPubMed
8.
Cox A, Jenkins V, Catt S, Langridge C, Fallowfield L (2006) Information needs and experiences: an audit of UK cancer patients. Eur J Oncol Nurs 10:263–272CrossRefPubMed
9.
Mallinger JB, Griggs JJ, Shields CG (2005) Patient-centered care and breast cancer survivors' satisfaction with information. Patient Educ Couns 57:342–349CrossRefPubMed
10.
Rehnberg G, Absetz P, Aro AR (2001) Women's satisfaction with information at breast biopsy in breast cancer screening. Patient Educ Couns 42:1–8CrossRefPubMed
11.
van Uden-Kraan CF, Drossaert CH, Taal E, Shaw BR, Seydel ER, van de Laar MA (2008) Empowering processes and outcomes of participation in online support groups for patients with breast cancer, arthritis, or fibromyalgia. Qual Health Res 18:405–417CrossRefPubMed
12.
Samoocha D, Bruinvels DJ, Elbers NA, Anema JR, van der Beek AJ (2010) Effectiveness of webbased interventions on patient empowerment: a systematic review and meta-analysis. J Med Internet Res 12:e23CrossRefPubMedPubMedCentral
13.
Bouma G, Admiraal JM, de Vries EG, Schroder CP, Walenkamp AM, Reyners AK (2015) Internetbased support programs to alleviate psychosocial and physical symptoms in cancer patients: a literature analysis. Crit Rev Oncol Hematol 95:26–37CrossRefPubMed
14.
Stichting NET-groep informatie over neuro-endocriene kanker. Available at: www.​net-kanker.​nl
15.
Arraras JI, Greimel E, Sezer O, Chie WC, Bergenmar M, Costantini A et al (2010) An international validation study of the EORTC QLQ-INFO25 questionnaire: an instrument to assess the information given to cancer patients. Eur J Cancer 46:2726–2738CrossRefPubMed
16.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376CrossRefPubMed
17.
Yadegarfar G, Friend L, Jones L, Plum LM, Ardill J, Taal B et al (2013) Validation of the EORTC QLQGINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours. Br J Cancer 108:301–310CrossRefPubMedPubMedCentral
18.
van Uden-Kraan CF, Drossaert CH, Taal E, Seydel ER, van de Laar MA (2009) Participation in online patient support groups endorses patients' empowerment. Patient Educ Couns 74:61–69CrossRefPubMed
19.
Manuals EORTC. Available at: http://​groups.​eortc.​be/​qol/​manuals. Accessed October 1, 2015
20.
European Commission. Available at: http://​ec.​europa.​eu/​health/​ehealth. Accessed January 21, 2016
21.
Lepore SJ, Buzaglo JS, Lieberman MA, Golant M, Greener JR, Davey A (2014) Comparing standard versus prosocial internet support groups for patients with breast cancer: a randomized controlled trial of the helper therapy principle. J Clin Oncol 32:4081–4086CrossRefPubMedPubMedCentral
22.
van de Poll-Franse LV, van Eenbergen MC (2008) Internet use by cancer survivors: current use and future wishes. Support Care Cancer 16:1189–1195CrossRefPubMed